MedPath

Efficacy of Vitamin D on serum levele of visfatin and vascular endothelial growth factor (VEGF)

Phase 2
Recruiting
Conditions
lcerative colitis.
Ulcerative colitis
Registration Number
IRCT20131125015536N7
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

People with a diagnosis of ulcerative colitis clinical examination to assess the colonoscopic biopsy and course of the disease in the medical record and confirmed by a gastroenterologist and liver that are in a state of Remission
People who volunteer to participate in the study
Age between 18 to 50 years old
BMI of 18.5 to 30

Exclusion Criteria

People in relapse status
Pregnant and lactating women
Anti-TNF-a drugs such as Infliximab
History of kidney stones and any diseases of the kidney, liver, cancer
Background taking any supplements containing vitamin D during the three months prior to the study
Diagnosis doctor to not being able to participate in the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath